stroke centre - search results
If you're not happy with the results, please do another search
New AHA statement should be seen as “call to action” in stroke centre certification
A new American Heart Association (AHA) scientific statement provides guidance on staffing, leadership and resource requirements for hospital stroke centres, with the intention of...
Gender disparity in comprehensive stroke centre routing highlighted at SNIS
Women may be less likely than men to be sent to a comprehensive, or “Level 1”, stroke centre for emergent large vessel occlusion (ELVO)...
Good outcomes doubled with primary stroke centre protocol, study shows
A study published online by JAMA Neurology has found that when a specific primary stroke centre protocol was fully executed in the treatment of...
One-third of Americans do not have access to stroke centre within one hour
Even under optimal conditions, a large proportion of the population would be unable to access a stroke centre within this window, according to a new study.
Elevating stroke care: Navigating the transition from primary to comprehensive centres
In a guest piece for NeuroNews, Thomas Devlin (Chattanooga, USA) and Michelle Luffey advise the community on how best to navigate the transition from...
Research indicates women are less likely to be routed to comprehensive stroke centres than...
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centres (CSCs), women with large vessel occlusion (LVO) acute ischaemic stroke...
Medtronic study finds post-stroke protocols “vary significantly” between community hospitals and academic centres
Medtronic has announced the first results from its DiVERT clinical study, which showed that post-stroke workflow protocols and cardiac monitoring vary significantly across community...
Brainomix awarded tender to roll out AI imaging software across all Hungarian stroke centres
Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...
Imperative Care announces positive, single-centre data on distal occlusion stroke treatment
Imperative Care recently announced that new data evaluating the utility of its Zoom stroke solution were presented at the 16th congress of the World...
SNIS 2022: Direct triage to Level 1 stroke centres reduces time to treatment and...
Implementing severity-based field triage leads to faster treatment and less disability for stroke patients, according to late-breaking research presented recently at the Society of...
PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment
PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...
ISC 2022: New study finds better outcomes in patients treated at advanced stroke centres
When comparing outcomes for acute ischaemic stroke patients treated at various levels of stroke centres, patients who received care at comprehensive stroke centres (CSC) or thrombectomy-capable...
Race among factors that predict how quickly patients get to stroke centres for essential...
Race, in combination with other factors, predicted how quickly individuals with stroke got to care centres to receive necessary neuroendovascular surgery, including thrombectomy, according...
ASA highlights value of comprehensive, patient-centred primary care after stroke
In a new scientific statement entitled “Primary Care of Adult Patients After Stroke”, the American Stroke Association (ASA)—a division of the American Heart Association...
Philips announces WE-TRUST multicentre clinical trial to assess impact of direct-to-angiosuite workflow on stroke...
Philips has announced a major clinical trial to assess the impact of a direct-to-angiosuite workflow on stroke patient outcomes. The study will assess whether...
Superior clinical outcomes for endovascular therapy candidates triaged directly to a comprehensive stroke centre
For patients with emergent large vessel occlusion (LVO) eligible for endovascular therapy, prehospital triage to a more distant comprehensive stroke centre (CSC) compared with...
Multicentre dataset reveals the added value of diffusion-weighted imaging to reduce perioperative stroke
Novel data from the Stroke from Thoracic Endovascular Repair (STEP) collaborators has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and...
The efficacy of endovascular stroke therapy outside of specialised centres needs further examination, concludes...
Real-world data investigating patient outcome after endovascular stroke therapy in high versus low volume centres finds a 30% increase in the likelihood of a...
From a primary to a comprehensive stroke centre: steps to success at St. Mary’s...
Advertorial
In 2008, St Mary’s Medical Center and the Palm Beach Children's Hospital in West Palm Beach, Florida USA, initiated an ambitious transition from a...
Treatment at high-volume centres more beneficial for stroke patients despite transfer effect
In a study published in the journal Stroke, Lorenzo Rinaldo and colleagues from the Mayo Clinic, Rochester, USA, have reported that transfer of acute...
Stanford Health Care recertified as advanced comprehensive stroke centre
Stanford Health Care has been recertified by The Joint Commission as an advanced comprehensive stroke centre, a designation reserved for institutions with specific abilities...
Why stroke patients should come to comprehensive stroke centres in the first place
By Andrei V Alexandrov
Major advancements in stroke treatment occurred this year: the standard of care has changed and we are now faced with the...
Comprehensive stroke centres may improve bleeding stroke survival
People with haemorrhagic strokes are more likely to survive if they are treated at a comprehensive stroke centre, according to research published in the Journal of the American Heart Association.
Stroke patients treated at stem cell research centre
Stem cell research institute of STC Life and 97.7 B&H Clinic successfully completed mesenchymal stem cell treatment for stroke patients.
Multicentre, retrospective data shows safety and efficacy of Solitaire FR as a first choice...
Data presented by Jan Gralla, Bern, Switzerland, at CIRSE 2011 in Munich, Germany, showed that Solitaire FR from ev3/Covidien had a good recanalisation rate and good patient outcome at 90 days, as measured by the modified Rankin Scale.
Brain Attack Coalition updates recommendations for primary stroke centres in the USA
The new recommendations recognise substantial changes in the diagnosis and treatment of stroke patients over the past decade particularly advances in brain and imaging techniques, the development of stroke teams and stroke units, and evidence supporting the importance of early initiation of rehabilitation therapy.
Mobile stroke units increase odds of averting strokes and achieving complete recovery
Receiving intravenous tissue plasminogen activator (IV-tPA) in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and the odds of a...
Tenecteplase deemed non-inferior to alteplase in suitable ischaemic stroke patients
The ATTEST-2 trial has found that tenecteplase was non-inferior to alteplase, the more established of the two thrombolytic agents, in suitable acute ischaemic stroke...
Perfuze enrols first stroke patient in MARRS pivotal trial of Millipede system
Perfuze has announced commencement of enrolment in its pivotal MARRS study—a multicentre trial set to evaluate the performance of aspiration thrombectomy with the company’s...
TENSION results show improved functional outcomes and reduced mortality with stroke thrombectomy
New results from the TENSION study—presented recently at the 15th World Stroke Congress (WSC; 10–12 October, Toronto, Canada) by Götz Thomalla (University Medical Center...
Contego announces low one-year stroke rates in PERFORMANCE II carotid stent trial
Contego Medical has announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual Vascular Interventional Advances (VIVA)...
Latest TRIAGE-STROKE and RACECAT data put the brakes on alternative stroke transfer protocols
Recently published data from two large randomised controlled trials (RCTs) have indicated there may be minimal benefits—or even negative effects—associated with bypassing local or...
Upcoming technologies set to forebear “new era” in prehospital stroke care
While the latest thrombectomy techniques, thrombolytic drug candidates and even neuroprotective agents are the source of much discussion in today’s neurovascular space, there is...
WSO predicts 50% more deaths unless “catastrophic” gaps in global stroke services are addressed
Between now and 2050—unless “urgent action is taken”—the number of people who die from stroke globally is estimated to increase by 50%, to 9.7...
‘Minimal differences’ in clinical outcomes between stroke thrombectomy with or without thrombolysis, meta-analysis signals
There are likely to be minimal differences in clinical outcomes between acute stroke patients presenting directly to endovascular treatment centres who undergo mechanical thrombectomy...
US registry study reveals 75% of acute stroke patients wait more than two hours...
A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than...
Smartphone app reliably and autonomously recognises physical stroke signs in study
During a late-breaking abstract session at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA), researchers discussed a...
New data indicate clinical benefits of Imperative’s Zoom stroke solution in large and distal...
Imperative Care has announced multiple new pieces of data from studies evaluating its Zoom stroke solution, presented at the ongoing Society of NeuroInterventional Surgery...
Highly targeted brain stimulation achieves “very exciting” outcomes in acute ischaemic stroke
Highly targeted electrical stimulation to the brain has shown promise as a treatment option for acute ischaemic stroke, according to a pilot study led by University...
MindRhythm announces first patient enrolment in pivotal study of novel stroke-detection device
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), recently announced that the first patient has been enrolled in the pivotal...
Analysis shows substantial cost saving can be achieved with Philips’ DTAS stroke pathway
Royal Philips has today announced the results of a health economics analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an “innovative approach” to the...
Vision recovery among potential benefits of endovascular therapy in PCA occlusion stroke
A multicentre study presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has found that vision recovery and an increased...
“Sonolysis is back” after safely reducing endarterectomy stroke risk in randomised trial
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...
Structured ambulatory post-stroke care “requires further evaluation” following mixed trial results
While patients treated via a structured ambulatory post-stroke care programme (SANO) in a recent cluster-randomised study experienced better control of their cardiovascular risk factors...
Remote ischaemic conditioning fails to improve functional outcomes in acute stroke patients
As per results from the RESIST study, remote ischaemic conditioning (RIC)—while not being associated with any major safety issues—has failed to improve functional outcomes...
AHA: Systemic interventions key to tackling “enormous inequities” in stroke care
‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn, work and play—have not...
MR CLEAN-LATE trial finds endovascular therapy safe and effective in late-presenting ischaemic stroke
Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present...
‘We need better tools’—new intracranial stent devices required for rare stroke pathologies
“Overall, we just need better tools” was one of the salient points delivered by Jane Khalife (Cooper University Health Care, Camden, USA) in a...
MIVI completes enrolment for study of Q revascularisation system in acute ischaemic stroke
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system...
Clinical stroke research in Canada receives million-dollar grant boost
The Heart and Stroke Foundation, Brain Canada, and the Canadian Stroke Consortium, have announced the recipients of the 2022 Stroke Clinical Research Catalyst grants. The purpose of this...
RapidAI receives US FDA 510(k) clearance for new imaging product to accelerate acute stroke...
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is...
New WIST guidelines seek to improve access and standardise training in stroke thrombectomy
A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in...
Evidence indicates effectiveness of brain stimulation in upper-limb stroke rehabilitation
Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and...
Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke patients
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...
First-pass effect or rule of three? Definition of procedural success remains imperfect in stroke...
While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many major clinical...
Paediatric case helps highlight benefit of ‘aspiration first’ in young stroke patients
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical...
Chest, Heart and Stroke Scotland applauds decision to reinstate “vital” thrombectomy funding
The charity Chest, Heart and Stroke Scotland (CHSS) has voiced support for the Scottish government’s decision to reinstate “vital” funding of thrombectomy services across...
Lessons learned from establishing a 24/7 stroke thrombectomy service
Alongside his colleagues at the Barts Health NHS Trust, Levansri Makalanda (London, UK) was responsible for setting up the second ever 24/7 mechanical thrombectomy...
Brainomix receives US FDA clearance for flagship stroke AI imaging software
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to...
Get Ahead of Stroke campaign debuts new online resources for EMS providers
With Brain Awareness Week (13–19 March) approaching, the Get Ahead of Stroke campaign has announced it is debuting new online resources for emergency medical...
Methinks receives CE-mark certification for AI-based stroke triage software
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of...
ANGEL-ASPECT data bolster evidence for thrombectomy in large infarct core stroke
A randomised trial has found mechanical thrombectomy procedures performed within 24 hours of symptom onset to be more effective than standard medical care in...
Thrombectomy appears comparable to medical management in treating ACA occlusion stroke
Mechanical thrombectomy appears to be a safe and technically feasible treatment option for ischaemic strokes caused by primary isolated anterior cerebral artery (ACA) occlusions...
Dual antiplatelet therapy comparable to thrombolysis in minor, non-disabling ischaemic stroke
Among Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet therapy (DAPT) has been found to be non-inferior to...
The positive clinical impact of a comprehensive, compatible stroke solutions portfolio
This advertorial is sponsored by CERENOVUS.
Following the recent addition of the EMBOGUARD balloon guide catheter (BGC) to the CERENOVUS STROKE SOLUTIONSi portfolio of devices,...
New certifications aim to standardise and improve stroke care in Mexico
Hospital institutions in Mexico will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Mexican stroke...
Celery seed derivative shows promise as neuroprotectant in acute ischaemic stroke
Ischaemic stroke patients treated with a clot-busting medication and/or mechanical thrombectomy who also received butylphthalide—a novel medication initially compounded from celery seed—experienced milder neurological...
Chinese TRACE II trial deems tenecteplase non-inferior to alteplase in ischaemic stroke
New data on intravenous tenecteplase indicate that it can achieve comparable efficacy and safety to alteplase in treating stroke—and, as such, may be used...
New smartphone app may help to identify stroke symptoms as they occur
A new smartphone application called FAST.AI (Neuronics Medical) may help people who are having a stroke—or their family and caregivers—to recognise common stroke symptoms in real...
SELECT2 results support thrombectomy use in stroke patients with large infarct-core volumes
An international clinical study has found that patients experiencing a ‘large’ stroke—characterised by a greater infarct-core volume on imaging—had a dramatically better recovery after...
ISC 2023 sees presentation of positive data on new stroke drugs and upcoming trials
New data pointing to the possible advantages held by several drug products in treating acute ischaemic stroke were delivered at the recent International Stroke...
Two cardiovascular medicines found to be “well-tolerated” in small vessel stroke
A study of two widely used cardiovascular medications—cilostazol and isosorbide mononitrate—in more than 350 patients has confirmed that both were well-tolerated and safe for...
Continuous monitoring detects atrial fibrillation in 20% of atherosclerotic stroke survivors
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in...
Prior thrombolysis improves outcomes for M2 occlusion stroke patients undergoing thrombectomy
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes than thrombectomy alone in stroke patients with M2 occlusions,...
Blackford and Brainomix announce partnership to advance AI-assisted stroke care
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution...
Hospitals without high-level designation more likely to miss strokes following TAVI procedures
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without the highest stroke care designation may be missing strokes that...
Challenging the status quo in stroke care
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and...
AHA statement: Even transient stroke symptoms require emergency assessment
Stroke symptoms that disappear in under an hour—often referred to as a transient ischaemic attack (TIA)—need emergency assessment to help prevent a full stroke,...
Neuroprotection “renaissance” offers hope for improved stroke therapies in future
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears...
Athersys provides update on ischaemic stroke and haemorrhagic trauma trials of stem cell treatment
Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided...
How do we improve the treatment of stroke patients in the future?
This educational supplement has been sponsored by MicroVention.
Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several...
Stroke community intensifies efforts to tackle “unacceptable” disparities in thrombectomy access
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through...
World Stroke Congress bolsters evidence on optimal thrombectomy and thrombolysis approaches
While much-needed improvements to existing triage and transport protocols for acute stroke patients were a leading topic of focus on World Stroke Day (29...
Brainomix and Visionable announce partnership to optimise UK stroke care pathway
Brainomix is set to strategically partner with Visionable, a real-time clinical collaboration platform designed to enable virtual healthcare models, in an attempt to transform...
BAOCHE trial results supporting thrombectomy for basilar artery stroke published in NEJM
Results from the BAOCHE randomised controlled trial (RCT), which found that the addition of thrombectomy to standard medical care within 6–24 hours in basilar...
World Stroke Day: WSO to launch new Stroke Certification initiative
On World Stroke Day (29 October 2022), the World Stroke Organization (WSO) has announced the launch of a new programme that aims to drive...
BE FAST: Physicians advocate greater public awareness on World Stroke Day
On World Stroke Day 2022 (29 October), US physicians from the Get Ahead of Stroke campaign are urging the public to embrace the “simple...
Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments
Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...
US study bolsters recent evidence supporting tenecteplase in ischaemic stroke care
Tenecteplase, a newer-generation intravenous thrombolysis (IVT) drug, has outperformed the traditional treatment (alteplase) for ischaemic strokes in several key areas, demonstrating better health outcomes...
TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection...
Among patients undergoing transfemoral transcatheter aortic valve implantation (TAVI), the use of a cerebral embolic protection device (Sentinel, Boston Scientific) did not have a...
How AI, automation, robotics and other innovations in ultrasound are improving stroke care
Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...
New data demonstrate effectiveness of Penumbra system and RED catheters for broad stroke care
Penumbra today announced initial INSIGHT registry data showing that its RED reperfusion catheters were successful in removing all clot types—and, additionally, results of sub-analyses...
SNIS 2022: Late-breaking data bolster evidence supporting thrombectomy for BAO stroke
Late-breaking research presented at the recent Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) has shown that thrombectomy procedures can...
Stroke Association calls for 24/7 thrombectomy service across the UK
A new report released by the UK Stroke Association warns that, if thrombectomy rates remain at 2020/21 levels, a total of 47,112 stroke patients...
SNIS 2022: COVID-19 may increase stroke risk in younger patients and cause poorer outcomes
Stroke patients with COVID-19 are facing worse outcomes, and are often younger and healthier, according to research presented recently at the Society of NeuroInterventional...
Imperative Care announces positive real-world data associated with Zoom stroke solution at SNIS 2022
Imperative Care has announced that new data from studies evaluating the utility of its Zoom stroke solution were recently presented at the ongoing Society...
Robotics, AI and other innovations in stroke and aneurysm care on the agenda for...
Specialists from around the world will gather at the Society of NeuroInterventional Surgery's (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) next week to discuss...
Tenecteplase shown to be effective for acute ischaemic stroke in large Canadian study
In what is claimed to be the largest stroke clinical trial ever run in Canada, researchers have shown that tenecteplase—a safe, well-tolerated drug commonly...
Alarming trends and alarmist myths: What is the link between COVID-19 and stroke?
Over the course of the past two years, the accepted understanding of how COVID-19 spreads and functions has improved vastly, with preventative vaccines and...
Rapid Medical begins enrolment in DISTALS trial treating new ischaemic stroke patient population
Rapid Medical announced today the enrolment of the first patient in the DISTALS study, which the company claims is the first-ever US Food and...
DISTAL: A landmark trial looking to elucidate endovascular treatment outcomes in MeVO stroke
In December 2021, University Hospital Basel (Basel, Switzerland) enrolled the first patient worldwide in the DISTAL study—a multicentre randomised controlled trial (RCT) evaluating the...
Vesalio announces completion of enrolment in acute ischaemic stroke IDE study
Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug Administration (FDA) investigational device exemption (IDE) study utilising the NeVa...
Study findings encourage direct EVT approaches over bridging thrombolysis in select stroke patients
A retrospective study involving more than 200 patients has indicated that ‘bridging thrombolysis’ may not be associated with improved functional outcomes in stroke patients...
MIT engineers develop joystick-operated robot to help surgeons treat stroke remotely
Engineers from the Massachusetts Institute of Technology (MIT) in Cambridge, USA have developed a telerobotic system to enable surgeons to quickly and remotely treat...
Study data indicate positive outcomes with “exciting new treatment option” in ischaemic stroke
Data from a multicentre clinical study supporting the use of Anaconda Biomed’s Advanced Neurovascular Access (ANA) catheter system for treating ischaemic stroke have been...
Why robotics holds the key to the future of stroke treatment
Vitor Pereira and Nicole Cancelliere (St Michael’s Hospital, Toronto, Canada) outline recent breakthroughs in the deployment of robotics for neurointerventional procedures and discuss future...
Newer clot-busting medication may someday increase time window for stroke treatment
In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...
ISC 2022: Global EXCELLENT study “shows how much stroke thrombectomy has advanced”
Mechanical removal of blood clots reduced post-stroke disability in nearly half of “all-comer” real-world stroke patients in a global study, according to preliminary late-breaking...
Reducing disability and death: What is next for stroke triage and transport?
Michael Chen (Rush University Medical Center, Chicago, USA) discusses the growing awareness around the need for timely interventions in stroke care in the USA,...
Dedicated primary care can reduce stroke risk in seniors by more than a fifth,...
ChenMed has announced results from a three-year study of nearly 60,000 patients, showing 22% lower incidence of primary stroke among those having benefitted from...
Enabling new possibilities in stroke treatment with Stream technology
This advertorial is sponsored by Perflow.
The StreamTM family of products (Perflow) is a range of dynamic neurothrombectomy net devices designed to give physicians greater...
Time savings, cost reductions and improved patient outcomes all key benefits of AI in...
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...
First patient enrolled in pivotal EMAGINE trial of electromagnetic field therapy for stroke recovery
BrainQ has announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital (Washington, USA) in the pivotal, randomised, double-blind, multicentre EMAGINE...
Women face increased risk of stroke and readmission after carotid interventions
A recent study has pointed to an increased risk of stroke in both asymptomatic and symptomatic female patients, as well as readmission in asymptomatic...
World Stroke Day 2021: Get Ahead of Stroke campaign pushes for updated US protocols
On World Stroke Day—29 October 2021—physicians from the Get Ahead of Stroke campaign are urging lawmakers to update triage and transport protocols. They are...
North Carolina updates stroke triage and transport protocol
North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...
Imperative Care enrols first patient in trial evaluating Zoom 88 Large Distal Platform for...
Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
TCAR yields “high technical success, with an extraordinarily low stroke and death rate at...
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularisation (TCAR; Silk Road Medical) treatment for carotid stenosis...
Sensome begins first-in-human trial of AI-powered stroke guidewire
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...
Flying intervention teams lead to higher EVT rates and reduced time to treatment for...
Flying teams of interventionists directly to a primary stroke centre to perform endovascular therapy (EVT)—as opposed to waiting for the patient to be transferred...
Five-year ACST-2 results: Carotid artery surgery and stenting have similar long-term effects on stroke
Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis. That is...
Time is brain: Travelling stroke team enables faster treatment and better patient outcomes
In a pilot programme in New York City, USA, a mobile interventional stroke team (MIST) travelled directly to patients to perform emergency stroke surgery...
Using new-generation CB-CT imaging tests may shorten time to surgery for stroke patients
Using a different type of computed tomography (CT) scan may reduce the time to essential surgery for patients with the deadliest kind of strokes—emergent...
Cerenovus to unveil new data and showcase stroke care innovations at SNIS annual meeting
Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, will showcase its latest innovations in stroke care at...
Brainomix launches AI stroke software across Poland under POLKARD initiative
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...
Repeated clot retrieval attempts linked to poorer functional outcome in acute ischaemic stroke patients
Repeated clot retrieval attempts are associated with an increased rate of emboli to new territory (ENT) and greater infarct growth—resulting in poorer functional outcomes...
Philips enrols first patient in WE-TRUST stroke study to assess new workflow approach
Royal Philips has announced that the first patient has been enrolled in the WE-TRUST (Workflow optimisation to reduce time to endovascular reperfusion for ultra-fast...
Viz.ai receives CE mark to bring AI-powered stroke care software to Europe
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...
New Stroke Association report to “shine a light” on stroke care’s biggest blind spots
The Stroke Association has announced the top areas of research that need to be prioritised to improve stroke care. The announcement of these priorities—which...
Stroke and heart condition patients want virtual healthcare to continue post pandemic, surveys indicate
After speaking with experts, reviewing current evidence, surveying people living with stroke or a heart condition, and funding a telephone poll of Canadians, the...
Higher incidence of severe stroke found in COVID-19 patients
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...
Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to EMEA region
Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...
Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment
US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...
First patient enrolled in MindRhythm trial to assess LVO stroke diagnostic device
MindRhythm, a US medical technology company focused on preventing neurological injury in stroke, has announced the enrolment of the first patient in a multicentre...
Research finds a decline in global stroke care during the pandemic
A study published in the journal Neurology concludes that despite the reported stroke-related complications of COVID-19, there has been a global decline in the volume of stroke...
First-pass success in mechanical thrombectomy lowers costs in treatment of acute ischaemic stroke in...
A recent Cerenovus study published in the Journal of Stroke (JOS) has found that in the treatment of acute ischaemic stroke, achieving complete or near...
Ischaemic stroke and TIA risk in COVID-19 patients lower than previously believed, study finds
The elevated risk of ischaemic stroke and transient ischaemic attack TIA in hospitalised COVID-19 patients may be lower than previously reported—although it is still...
Viz.ai announces new data on AI stroke platform
Viz.ai presented new data supporting the use of its technology to coordinate care for acute ischaemic stroke, haemorrhagic stroke, and clinical trial recruitment at...
Sevaro Health launches its telestroke platform Sevaro OneCall
Sevaro Health has announced the launch of Sevaro OneCall, a proprietary platform which, according to a company press release, enables immediate access to neurologists...
Mobile stroke units may “result in lower rates of disability”
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17 –19 March, online) has presented evidence that patients who received care from...
Immediate angiography may reduce stroke treatment time
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17–19 March, online) reports that immediate angiography, rather than the standard computed tomography (CT scan), reduced...
Differences found in stroke severity and post-stroke care among Black and Hispanic women
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (17–19 March, virtual) has found that Black and Hispanic women aged...
Even short delays in the ER reduce the lifespan of stroke survivors, study finds
Research to be presented at the International Stroke Conference (ISC) 2021 meeting (17-19 March, virtual) has found that for every 10-minute delay between arrival...
New research may help prevent recurrent strokes
Results from a phase II clinical trial conducted by vascular neurologists at Cedar-Sinai, Los Angeles, USA, show there is potential to reduce the rate...
New study supports Anaconda Biomed’s ANA catheter system for ischaemic stroke
New single-centre clinical study data published in the Journal of Neuroradiology claims to support the Anaconda Neurovascular Access (ANA) catheter system for the treatment...
The relevance of a strong healthcare system for acute stroke care during the COVID-19...
Blanca Fuentes, María Alonso de Leciñana, and Exuperio Díez Tejedor write about the challenges faced in the management of stroke care throughout the pandemic,...
Global drive to increase awareness, action and access to mechanical thrombectomy for stroke patients
Mission Thrombectomy 2020+ (MT2020+), a global campaign of SVIN (Society of Vascular and Interventional Neurology), recently published Mechanical Thrombectomy for Acute Stroke. Building Thrombectomy...
PRESTO shows pre-hospital stroke scales detect aLVO with “acceptable-to-good accuracy”
Pre-hospital stroke scales detect anterior circulation large vessel occlusion (aLVO) with acceptable-to-good accuracy, according to PRESTO, a large prospective observational study, the results of...
First-pass effect lowers costs in treatment of acute ischaemic stroke, study finds
A study published in the British Medical Journal (BMJ) has found that first-pass effect (FPE), restoring complete or near complete reperfusion (modified Thrombolysis in...
Stroke increases risk of death of COVID-19, according to new study
A study published in Neurology claims that people hospitalised with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying...
Testing Artificial Intelligence software used to identify stroke features
Grant Mair, the Stroke Association’s Edith Murphy Foundation Senior Clinical Lecturer, University of Edinburgh, and honorary consultant neuroradiologist, NHS Lothian, Scotland. At the ESC-WSO...
NICO.LAB receives FDA clearance for AI stroke care solution
NICO.LAB has received clearance from the US Food and Drug Administration (FDA) for its artificial intelligence (AI) powered solution in stroke care, StrokeViewer LVO.
According...
ESO-WSO: AI can be used for automatic segmentation of stroke infract volume
A study presented by Kelvin Wong (Houston Methodist, Houston, US) at the European Stroke Organisation and the World Stroke Organization joint virtual conference (ESO-WSO...
Three centres’ experience with the Siemens ARTIS icono system: A NeuroNews webinar
Azam Ahmed (Madison, USA; moderator) was joined by Demetrius Lopes (Chicago, USA) and Dan Gibson (Milwaukee, USA) as part of a special live NeuroNews webinar titled ‘Early adopters are changing the game in neurointerventional surgery’.
The webinar gave...
Brainomix achieves ‘breakthrough’ in stroke imaging with new software release
Brainomix has announced the launch of the latest version of the company's stroke imaging platform, e-Stroke Suite 10.0, which includes clot detection from non-contrast computed tomography (CT) scans and is designed to...
Stroke treatment in the fast lane
The last five years have seen endovascular therapy for patients with acute ischaemic stroke proven undeniably effective, changing the face of stroke treatment forever.
While...
News from SNIS: New study finds racial disparities in acute stroke thrombectomy management
A new study has found several racial disparities after mechanical thrombectomy for stroke with respect to post-procedure management and outcomes. Vineeth Thirunavu of Northwestern...
News from SNIS: Bridging therapy independently predicts haemorrhagic complications in atrial fibrillation associated stroke
Exposure to bridging therapy independently predicts haemorrhagic complications—without improving functional outcomes—in patients with atrial fibrillation (AF) associated stroke. The findings from this retrospective, registry...
LIVE from SNIS: The stroke trials you need to know about
From acute interventions to endovascular therapy indication expansion, Sunil Sheth from McGovern Medical School at UTHealth, Houston, USA, kick-started the Society of NeuroInterventional Surgery’s...
LIVE from SNIS: New study validates use of RACE scale for stroke triage
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting (4–7 August, virtual meeting) serves as the first prospective validation...
Endovascular therapy fails to outperform best medical management in basilar artery occlusion stroke
Final results of the Basilar artery international cooperation study (BASICS) have been reported by Wouter J Schonewille (University Medical Centre Utrecht, Utrecht, the Netherlands)...
Research versus reality: Stroke care amid COVID-19 and beyond
Mayank Goyal and Johanna Ospel, both from the University of Calgary, Alberta, Canada, talk to NeuroNews about the challenges facing stroke care five years...
COVID-19 patients are “hypercoagulable and at an increased risk for stroke”
The association between COVID-19 and the increased incidence of stroke continues to grow. Situated within the pandemic’s epicentre, Kurt Yaeger and J Mocco, neurosurgeons...
Stroke care in London as pressure on NHS rises amid COVID-19
Following the announcement that the UK will remain on lockdown for the foreseeable future, NeuroNews speaks to Shahram Derakhshani about the impact of COVID-19...
Brain stents are safe and effective for reducing recurrent stroke risk, study suggests
A brain stent appears safe and effective for reducing the risk of recurrent stroke in patients with cholesterol-clogged brain arteries, according to late-breaking data...
Live from ISC: Wearable brain stimulation could safely improve motor function after stroke
A new, non-invasive wearable magnetic brain stimulation device to improve recovery for stroke survivors has been deemed safe and effective. David Chiu, director of...
Quick and easy imaging interpretation for stroke therapy: The promise of a new multiphase...
Stroke treatment is time-sensitive. Every minute counts. Every delay in decision-making affects patient outcome. Given this, JM Ospel and colleagues from the University of...
US FDA clears Aidoc’s complete AI stroke package
Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
Although “unperfected”, AI has the potential to accelerate and synchronise stroke care
A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
Brainomix AI software improves stroke treatment rates at Budapest University Hospital
On the 8th of November 2019, during a symposium at the annual meeting of the Hungarian Neuroradiology Society (MNRT) in Mátraháza, Hungary, Bence Gunda...
TSI enrols first 10 patients in its phase 2 ischaemic stroke trial and completion...
Thrombolytic Science (TSI) has announced progress with 10 patients enrolled in its prospective, randomised, multicentre phase 2 clinical trial, designed to confirm the safety...
RAPID platform expands to address haemorrhagic stroke
iSchemaView has launched the newest addition to the RAPID platform, RAPID ICH at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting (19–23 October,...
Aidoc releases complete AI package to speed identification and treatment of stroke
Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...
Overlook Medical Center participates in study evaluating best medical management for haemorrhagic stroke
Overlook Medical Center’s Atlantic Neuroscience Institute is set to participate in the MIND trial: a prospective, multicentre, randomised controlled trial (RCT) examining the Artemis...
South Florida partnership working to save lives using data to guide stroke triage decisions
A progressive emergency medical services (EMS)–driven partnership in South Florida (USA) has expedited access to lifesaving care for stroke patients. This groundbreaking effort to...
A stroke trial update from SNIS 2019
From tPA augmentation and stroke systems of care through to the rise of neuroprotective investigations, Santiago Ortega-Gutiérrez, University of Iowa (Iowa City, USA) kick...
Big data set to increase the efficiency of stroke outcomes research
A topical review published in Stroke investigates new approaches for the collection of outcomes data after stroke. In the context of global technological growth,...
RAPID imaging platform expands options for speedy stroke treatment at Atlantic Health System Neuroscience
Recognising how vital it is that stroke neurosurgeons and neurologists receive timely information about the type of stroke a person is having so they...
Alteplase at 0.6mg/kg for stroke with unknown time of onset is deemed safe, but...
Although an acceptable safety profile was demonstrated for MRI-guided thrombolysis with alteplase at 0.6mg/kg for stroke with unknown time of onset, the latter approach...
Ambulance administration of transdermal glyceryl trinitrate does not improve outcomes in patients with acute...
A study in which ambulance paramedics treated patients suspected of having an acute stroke with transdermal glyceryl trinitrate (GTN) to lower their blood pressure...
Interdisciplinary approach to in-hospital stroke improves detection and treatment time
A recent study found that revision of an existing in-hospital stroke (IHS) protocol was associated with a lower rate of stroke mimics, and shorter...
Many stroke patients not screened for osteoporosis, despite known risks
The majority of stroke survivors are not screened or treated for osteoporosis, broken bones, or fall risk—despite stroke being a risk factor for these...
Insera earns CE mark approval for cyclical-suction stroke thrombectomy platform, the CLEAR aspiration system
Insera Therapeutics has announced that it has received CE mark approval for its flagship product, the CLEAR Aspiration System, for the aspiration of blood...
The blood pressure paradox in acute ischaemic stroke “lies in the modifying effect of...
The relationship between blood pressure and outcomes is highly dependent on reperfusion, conclude Lang Hong (Fudan University, Shanghai, China) and colleagues on behalf of...
Artificial Intelligence in prehospital stroke detection: Automation in motion
Acknowledging the current limitations that hinder optimal stroke screening in the prehospital setting, Mark McDonald (University of Virginia, Charlottesville, USA), one of the co-founders...
Reperfusion promotes favourable outcomes in ischaemic stroke patients with ASPECTS 0–5 treated with mechanical...
In a subgroup of acute ischaemic stroke patients presenting with Alberta stroke program early CT score (ASPECTS) 0–5, who were treated with mechanical thrombectomy,...
Presented at the ISC: PHAST-TSC trial for treatment of acute stroke
Following the American Heart Association’s International Stroke Conference (ISC; 5–8 February, Hawaii, USA), Diffusion Pharmaceuticals announce a poster presented at the conference, outlining the...
Standard treatment of hyperglycaemia in acute ischaemic stroke outperforms an intensive approach
Intensive glucose control (80–130mg/dL) does not improve 90-day functional outcome and increases the risk of severe hypoglycaemia. This is the conclusion presented by Karen...
Patrick Lyden receives eminent American Stroke Association Award
Patrick D Lyden, a world-renowned stroke expert who played a key role in the pivotal clinical trial leading to approval of the first proven...
Acute ischaemic stroke care continuum: With stroke patients every step of the way
The fact that endovascular therapy is now well established for patients with acute ischaemic stroke has changed the face of stroke treatment forever. The last five...
FDA clears RAPID imaging platform for use in selecting acute stroke patients for clot...
iSchemaView has announced that the US Food and Drug Administration (FDA) has cleared the RAPID neuroimaging platform for use in selecting stroke patients who...
RACECAT trial comparing transfer of acute stroke patients enrols 715 patients
The preliminary results of the RACECAT trial—a study comparing transfer of acute stroke patients with suspected large vessel occlusion (LVO) to the closest local...
Favourable revascularisation rates for first-in-man results of the Versi Retriever in acute ischaemic stroke
First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...
The evolving role of telemedicine in acute stroke treatment
Amid the current modernisation of ischaemic stroke treatment, Michael Chen discusses how telemedicine not only has tremendous value, but should become a more standard...
Canadian-led international study shows huge costs of delayed access to stroke care
It has been known for years that it is important to get stroke patient’s treatment as soon as possible to increase their chances of...
International neurointerventional societies outline new criteria for facilities that treat stroke
Thirteen neurointerventional societies have released new guidelines outlining the criteria for Level 1, 2 and 3 stroke centres that provide acute ischemic stroke interventions...
Innovative on-ambulance PHAST-TSC trial for treatment of acute stroke approved by FDA
Diffusion Pharmaceuticals, a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where...
Stroke patients treated at a teaching hospital are less likely to be readmitted
Stroke patients appear to receive better care at teaching hospitals with less chance of landing back in hospital during the early stages of recovery,...
Standardised stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardised stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon...
Time delays to thrombectomy for stroke reduce patient lifetime and economic value of care
Every minute that endovascular thrombectomy (EVT) for a stroke patient is delayed decreases the patient's quality of life and lifespan, and reduces the significant...
Clinical study looking into mechanical thrombectomy for major stroke starts in eight European countries
The TENSION research project is to conduct a clinical study to show whether patients affected by severe strokes can also benefit from the mechanical...
Stroke public education campaigns need to raise awareness of TIAs
A new study has found that public messaging for stroke needs to be tailored to include advice on transient ischaemic attacks (TIA) and minor...
Portable device detects severe stroke with 93% sensitivity
The volumetric impedance phase shift spectroscopy (VIPS) device is a portable, noninvasive way of detecting severe stroke, including emergent large vessel occlusion (ELVO), with...
How to treat ischaemic stroke fast: Getting the correct patient to the correct hospital
“The single biggest challenge going forward is the organisation of stroke care,” says Mayank Goyal (University of Calgary, Canada). He dissected the arguments at...
Life-saving stroke educational program goes global
In an effort to improve stroke recognition and reduce life-threatening pre-hospital delays worldwide, an international team lead by researchers at Penn Medicine (Philadelphia, USA)...
WAKE-UP trial shows that thrombolysis can benefit certain stroke patients with unknown time of...
In patients with unknown symptom onset stroke with MRI pattern of DWI-FLAIR-mismatch, treatment with alteplase resulted in better functional outcome than placebo. These benefits...
Multicentre study shows Derivo embolisation device to be safe and effective in treating unruptured...
Endovascular treatment of unruptured intracranial aneurysms with the Derivo (Acandis) embolisation device is associated with high procedural safety and adequate occlusion rates. All procedures...
Use of RACE scale may result in faster time to thrombectomy in large vessel...
By Hannah Woolley
The RACE scale has been successfully used by emergency medical services (EMS) agencies to reduce door to arterial puncture times for acute...
Endovascular thrombectomy for mild strokes: How low should we go?
Amrou Sarraj shares his research on the use of thrombectomy for mild strokes and thrombectomy as an appropriate treatment.
Recent trials have established that endovascular...
New study shows use of EmboTrap device clot retriever during treatment of stroke yields...
A device designed to remove clots from the brain following an ischaemic stroke, the EmboTrap demonstrated high success rates in restoring blood flow and...
The burden of stroke: A global perspective
The landscape of stroke care has begun to change as a direct response to the growing research and breakthroughs in the approach to stroke...
Shorter treatment times for endovascular therapy with “trip-and-treat” stroke model
A team at Mount Sinai Hospital in New York, USA, has shown that their trip-and-treat model is associated with shorter treatment times for endovascular...
ARISE II results show two-thirds of ischaemic stroke patients return to previous functional ability...
EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes...
“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute ischaemic stroke
Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...
The Joint Commission, American Heart Association/American Stroke Association announce new thrombectomy certification
The Joint Commission, in collaboration with the American Heart Association/American Stroke Association, the world’s leading voluntary health organisation devoted to fighting cardiovascular disease and...
Significant improvement in time-to-treat in acute stroke patients with STEPS-T
Advertorial
An interventional neuroradiology team has recorded significant improvement in time-to-treat in acute ischaemic stroke patients treated with mechanical thrombectomy over a five-year period. The...
Two trials validate use of image-based selection for late window stroke patients
With the results of the DAWN trial now published in the New England Journal of Medicine and the late time window data from the...
Real-life use of EmboTrap shows comparable outcomes to large stroke studies
The real-life use of the EmboTrap device (Neuravi/Cerenovus) has provided “very good outcomes” when compared to that observed in large mechanical thrombectomy trials which...
Virtual reality training may be as effective as regular therapy after stroke
Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular therapy, according to a study...
John Muir Health awarded Comprehensive Stroke Certification Accreditation
John Muir Health’s Walnut Creek Medical Center, Walnut Creek, USA, has been awarded Comprehensive Stroke Certification Accreditation by The Joint Commission, which accredits and...
Door-to-puncture in 15 minutes: one centre’s goal
One New York City-based centre is projecting that door-to-puncture times for the endovascular treatment of acute ischaemic stroke patients can be reduced to as...
First patient enrolled in TIGERTRIEVER acute ischaemic stroke registry
The first patient has been enrolled in the TIGERTRIEVR registry at the Cantonal Hospital of Lucerne, Switzerland. The Tigertriever (Rapid Medical) is a one-of-a-kind, fully-visible,...
VITAL study shows promise for early identification of serious strokes
The results of the VITAL study demonstrate that a non-invasive, visor-like neurological device (VIPS technology from Cerebrotech Medical Systems) can identify those patients with...
Helistroke service: flying the physician to the stroke patient works
Flying a stroke specialist by helicopter to a nearby stroke patient for emergency care is feasible, saves money and, most importantly, gets critical care...
Worse outcomes with general anaesthesia in pooled analysis of stroke patients
Data from the pooled analysis of the HERMES collaboration have shown that stroke patients given endovascular treatment under general anaesthesia experienced worse outcomes than...
New process designed to streamline faster care for EMS triage, transport of stroke patients
A new process, developed by the American Heart Association/ American Stroke Association, will help streamline the initial emergency care of stroke patients. The new Severity-based...
Study shows stem cell therapy is safe for stroke patients
A multicentre trial exploring whether a single dose of millions of adult, bone-marrow-derived stem cells can aid stroke recovery indicates it is safe and...
ESO-ESMINT-ESNR host annual Stroke Winter School
The European Stroke Organisation (ESO), together with the European Society of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR), endorsed...
ASTER RCT finds no significant difference between ADAPT and stent retriever as frontline strategy...
The primary results of the ASTER randomised controlled trial (RCT) have shown no statistically significant difference between ADAPT (a direct aspiration first pass technique)...
First patient enrolled in haemorrhagic stroke RCT
The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the...
Expelling bottlenecks key to enhancing stroke pathways of care
There is no doubt now that mechanical thrombectomy has been established as the new standard of care for the treatment of emergent large vessel...
Women, minorities may be undertreated for stroke
Women and minorities may be less likely to receive treatment for stroke, according to a study published in a recent online issue of Neurology,...
Interhospital transfer responsible for delays in revascularisation in stroke patients
Data from the STRATIS registry presented at the Society of NeuroInterventional Surgery annual meeting (SNIS; 25–28 July, Boston, USA) show that the transfer of...
Long-term experience confirms ADAPT as effective treatment for stroke
A study of the long-term use of the ADAPT technique for the treatment of acute ischaemic stroke has confirmed that it is an efficient...
Inside the NIH StrokeNet
The National Institutes of Health (NIH) StrokeNet, which was initiated in 2013, currently involves 288 hospitals across the United States and is designed to...
Debate: IV thrombolysis in acute stroke treatment is dead
It has now been universally accepted that mechincal thrombectomy for the treatment of patients with acute ischaemic stroke with large vessel occlusions is the...
There is a “place” for MR imaging in acute stroke
Magnetic resonance (MR) imaging may have advantages over other imaging modalities in later time windows when it comes to selecting patients for endovascular treatment...
Quality over quantity: Consensus document outlines training guidelines for ischaemic stroke intervention
Twelve international societies have joined together to produce a consensus document to guide physicians seeking to treat acute ischaemic stroke patients with mechanical thrombectomy...
Implementing endovascular treatment for acute ischaemic stroke as the standard of care: The Madrid...
Recent evidence demonstrating the effectiveness of endovascular treatment with mechanical thrombectomy for acute ischaemic stroke due to proximal large vessel occlusion in the anterior...
SVIN releases consensus criteria for standardising stroke infrastructure
The Society for Vascular and Interventional Neurology (SVIN) has developed Stroke Interventional Laboratory Consensus (SILC) criteria to standardise stroke interventional laboratories for safe, effective,...
SVIN publishes recommendations for endovascular therapy of acute stroke
A new set of recommendations from the Society for Vascular and Interventional Neurology (SVIN) on endovascular stroke care has been published online in Interventional...
SITS Open stroke trial includes phenox pREset thrombectomy device
The phenox pREset and pREset LITE thrombectomy devices have been included in the study portfolio of the SITS Open clinical trial. Two other devices...
NICO announces BrainPath haemorrhagic stroke trial
Two of Atlanta’s stroke centres, associated with Emory University School of Medicine, have joined NICO (Neurosurgical Intervention Company) to perform a randomised controlled trial...
Outcomes of UK stroke trial consistent with other published data
The results of the UK-based PISTE trial demonstrate that the outcomes are consistent with the published data from similar mechanical thrombectomy acute ischaemic stroke...
Rapid symptom improvement does not imply better stroke recovery
The rapid improvement of symptoms before arrival at hospital does not always lead to better recovery for stroke patients, according to new research presented...
Clot-busting treatment safe and effective for patients who required living assistance pre-stroke
Intravenous clot busting may be safe and effective in patients with pre-existing dependency, according to new research published in the American Heart Association journal,...
Why I use aspiration as my first line treatment for acute ischaemic stroke
By Aquilla Turk
In the last year, five prospective randomised clinical trials have demonstrated the superiority of endovascular thrombectomy over medical management for the treatment...
IMS III and MR CLEAN pooled analysis validates endovascular therapy for severe ischaemic stroke
To conduct the analysis, investigators from both trials assessed the effect of endovascular treatment in acute ischaemic stroke patients with severe neurological deficit (National...
Treatment of brain haemorrhage after thrombolysis for stroke not associated with reduced chance of...
According to an article published by the Journal of the American Medicine Association (JAMA) Neurology, treating symptomatic intracerebral haemorrhage (sICH) after clot-busting thrombolysis for...
60 minutes or less: Time to reperfusion in acute stroke therapy must be reduced
The efficacy of intra-arterial therapy for the treatment of acute ischaemic stroke has now been established, but it has also been observed that the...
Aperio device effective and safe in treatment of acute stroke
In a multicentre study, the Aperio thrombectomy device (Acandis) demonstrated safety and efficacy as a tool for reopening occluded cerebral arteries in the setting...
Mobile stroke units may improve survival rates for ischaemic stroke patients
Two new studies presented at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, USA, report that Mobile Stroke Treatment Units (MSTUs)...
Uric acid may lessen women’s disability after stroke
Uric acid—a chemical that at high levels can lead to serious illness—may lessen women’s disability after stroke, according to new research in the American Heart...
Uric acid may lessen women’s disability after stroke
Uric acid-a chemical that at high levels can lead to serious illness-may lessen women's disability after stroke, according to new research in the American Heart Association's journal Stroke.
Rapid response to children’s stroke symptoms may speed diagnosis
An emergency room rapid response plan for children can help diagnose stroke symptoms quickly, according to new research in the American Heart Association journal Stroke.
“Just as there...
Stent retrievers now recommended for some stroke patients
For the first time, the American Heart Association/American Stroke Association recommends using a stent retrieval device to remove blood clots in select stroke patients...
Neuravi announces €19m in financing to advance innovative minimally invasive stroke therapy
L to R: Justin Lynch, partner, Fountain Healthcare Partners, Eamon Brady, chief executive officer, Neuravi and John O’Shaughnessy, chairman, Neuravi
Neuravi has completed a Series...
NIH names Walter J Koroshetz director of the National Institute of Neurological Disorders and...
National Institutes of Health director Francis S Collins has announced the selection of Walter J Koroshetz, as the Director of the National Institute of...
Stroke education helps patients recognise stroke symptoms; encourages fast response
Intense education can help stroke survivors quickly recognise symptoms of a subsequent stroke and seek prompt treatment, according to a study in Stroke, Journal of...
Weekly non-invasive brain stimulation provides long-term relief of post-stroke pain
Weekly sessions of non-invasive repetitive transcranial magnetic stimulation provided sufficient long-term pain relief in 61% of patients with central post-stroke pain, and delivered long-term...
FDA clears Penumbra ACE64 for acute ischaemic stroke patients
Penumbra has announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the US Food and Drug Administration for the revascularisation...
A SMARTer approach to stroke care
Time is critical when it comes to stroke, and early treatment is associated with better outcomes. According to the Screening with MRI for Accurate...
New day in acute ischaemic stroke therapy
By Joseph Broderick
The publication and presentation of four endovascular trials for acute ischaemic stroke has evoked a number of metaphors: “sea change”, “new day”,...
Evidence builds for endovascular treatment of acute ischaemic stroke
With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT add to that of three other trials-MR CLEAN, EXTEND-IA and ESCAPE-that have begun to change the face of ischaemic stroke treatment.
AANS, CNS and Joint Cerebrovascular Section endorse interventional thrombectomy in treatment of acute ischaemic...
The three groups endorse the approach in their article, "MR CLEAN: past the tipping point of clinical equipoise," by Henry H Woo et al, published online, ahead of print, in the Journal of Neurosurgery.
Use of stent, compared to medications, increases risk of stroke in VISSIT trial
The VISSIT study has shown that among patients with symptomatic intracranial arterial stenosis, the use of a balloon-expandable stent compared with medical therapy (clopidogrel and aspirin) resulted in an increase of stroke or transient ischaemic attack.
Blood flow technology from VasSol Identifies risk of recurrent stroke
The results, presented at the International Stroke Conference (Nashville, USA, 11-13 February, 2015) are expected to substantially improve both the study and treatment of stroke.
US stroke patients receiving better and more timely care
More ischaemic stroke patients are now being quickly transferred to certified US stroke centres, according to research presented at the American Stroke Association's International Stroke Conference 2015.
Groundbreaking studies find that neurointerventional surgery reduces stroke mortality
Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.
Transradial access valid for treatment of acute ischaemic stroke
According to a recent retrospective review published in the Journal of NeuroInterventional Surgery, the transradial approach to mechanical embolectomy is a valid approach for the endovascular treatment of acute ischaemic stroke.
TeleStroke Units improve stroke care in underserved areas
By Peter Müller-Barna
In rural areas inhabitants often do not have direct access to specialised Stroke Units. But in fact, it is well known that Stroke...
Stroke falls to No. 5 cause of death in USA
Stroke has dropped from the USA's fourth-leading cause of death to No. 5, according to new federal statistics.
MR CLEAN: Better outcomes with intervention in ischaemic stroke patients
For the first time, the Multicentre randomised clinical trial of endovascular treatment for acute ischaemic stroke in the Netherlands (MR CLEAN) has shown better outcomes in favour of intervention in patients with acute ischaemic stroke.
Stroke treatment in England varies widely by location
The figures released by the HSCIC show that the percentage of patients admitted to an acute stroke unit within four hours of arrival at hospital varied from 22% to 85% across different clinical commissioning groups.
Repetitive transcranial magnetic stimulation studied for stroke rehabilitation
Researchers at The Ohio State University Wexner Medical Center are attempting to improve arm movement in stroke patients by using a transcranial magnetic stimulator (TMS) device.
Costs to treat bleeding strokes increases 10 years later
Costs to treat strokes caused by bleeding in the brain may increase significantly 10 years later, according to a study in the American Heart Association journal Stroke.
Stenting safe and effective for long-term stroke prevention
Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term prevention of fatal and disabling strokes, reports an international trial led by University College London.
Low education, smoking, high blood pressure may lead to increased stroke risk
Adult smokers with limited education face a greater risk of stroke than those with a higher education, according to new research in the American Heart Association's journal Stroke.
Early brain stimulation may help stroke survivors recover language function
By Dieter Heiss
Aphasia, the most disabling functional defect after ischaemic stroke, affects more than a third of all stroke victims and recovery in most...
Stroke inpatient rehabilitation facilities yield better neurological outcomes than skilled nursing facilities
A demographic analysis has revealed that an association exists between discharge disposition and National Institutes of Health Stroke Scores (NIHSS) at 90-day follow-up.
AHA funds new research network aimed at preventing heart disease, stroke
The American Heart Association is funding a new research network to help people make behaviour changes to prevent heart disease and stroke, the two leading causes of death in the world.
Clinical trial tests possible benefits of brain stimulation on hand and arm movement following...
Researchers at Shepherd Center, Atlanta, USA, are studying whether stimulating the brain before rehabilitation could yield greater gains in motor function for people recovering from stroke. Researchers believe that the new approach could change common practices of care for certain stroke patients.
NeuroVascular Quality Initiative launches first procedure module: Acute Ischaemic Stroke
The Society of NeuroInterventional Surgery and M2S announced the launch of the NeuroVascular Quality Initiative, a multi-module registry system designed to track performance and outcomes data across a variety of neurovascular conditions. The launch debuts the Acute Ischaemic Stroke module, which will be used to track and benchmark clinical performance at the centre level and nationally.
ADAPT a safe and simple technique for ischaemic stroke thrombectomy
A direct aspiration first pass technique (ADAPT) with a large bore aspiration catheter has been shown to be "fast, safe, simple and effective method" for acute ischaemic stroke thrombectomy. The results were published in the Journal of of NeuroInterventional Surgery.
Stroke survivors may lose month of healthy life for 15-minute delay in treatment
Every 15-minute delay in delivering a clot-busting drug after stroke robs survivors of about a month of disability-free life, according to a new study in the American Heart Association journal Stroke.
Intracranial carotid artery atherosclerosis associated with increased stroke risk
A build-up of plaque in the carotid artery above the neck was associated with an increased risk of stroke for older white patients in a recent study.
National stroke summit tour to bring physicians across the USA together to advance optimal...
The Society of NeuroInterventional Surgery (SNIS) on 9 January has launched a 2014 national tour that will bring together physicians and medical personnel across the USA involved in stroke care to address current stroke treatment and the value of neurointerventional therapy in optimal stroke care delivery.
A long walk may lower stroke risk in older men
Older men who walked at least one to two hours each day compared to less than half an hour per day had a reduced risk of stroke, a large population-based study reported in Stroke says.
New study suggests endovascular therapy may improve quality of life for stroke patients
According to recent research published in the September 2013 edition of Journal of Stroke and Cerebrovascular Diseases, patients see better results when they receive endovascular treatment at a dedicated stroke centre.
First experience in using a novel operator-independent ultrasound device in stroke-free volunteers
Kristian Barlinn
As controversies exist concerning the effectiveness of sonothrombolysis and as to whether it can be broadly implemented as an adjunctive treatment approach for...
In mild strokes, ultra-early treatment may eliminate risk of disability
In the case of mild or moderate strokes, getting treatment ultra-fast (within 90 minutes of experiencing symptoms) reduces the risk of suffering disability, according to a new study reported in the American Heart Association's journal, Stroke.
It is not as simple as “intra-arterial acute ischaemic stroke therapy does not work”
By David Sacks
In February 2013, three trials of intra-arterial acute ischaemic stroke therapy were presented and then published in the New England Journal of Medicine....
FIRST trial provides real-world data on natural evolution of ischaemic stroke in patients untreated...
The FIRST trial, a prospective, multicentre study sponsored by Penumbra, provides data to assess the natural history of stroke in a population of patients who, circumstances notwithstanding, would have otherwise been treated with intra-arterial therapy.
Penumbra launches 5Max-Ace to treat acute ischaemic stroke
On 8 July, Penumbra announced the launch and wide availability of the 5Max Ace, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots that cause an acute ischaemic stroke.
CLOTS 3 study shows sequential compression sleeves reduce deep vein thrombosis events in immobile...
Intermittent pneumatic compression, in which thigh-length sleeves are used to compress the veins in the legs, mimicking the effects of walking, is an effective method of reducing the risk of deep vein thrombosis and possibly improving survival patients who are immobile after stroke, the study reveals.
Medical societies unite on patient-centered measures for nonsurgical stroke interventions
The Society of Interventional Radiology has published guidelines that capture consensus on clinical practice of intra-arterial stroke revascularisation.
Internet-based survey shows patterns of variability in neurointerventional practice for acute ischaemic stroke
A study, published in the Journal of NeuroInterventional Surgery and conducted by Brijesh P Mehta, Boston, USA, and colleagues has assessed the variability in neurointerventional practice for intra-arterial therapy with tPA for patients with major acute ischaemic stroke secondary to large vessel occlusions.
Covidien opens patient enrolment for SWIFT PRIME acute ischaemic stroke study
A new clinical trial from Covidien aims to examine the effectiveness of advanced mechanical thrombectomy in the treatment of stroke.
Intra-arterial revascularisation with stents safe and effective for stroke patients with contraindication for intravenous...
Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online ahead-of-print in the 11 December issue of the journal Radiology.
Stroke treatment performed by interventional radiologists in collaboration with diagnostic neuroradiologists and stroke neurologists...
Lars Fjetland, Stavanger, Norway, and others investigated the possibility of collaboration between vascular interventional radiologists, diagnostic neuroradiologists and stroke neurologists for neurointerventional treatment of acute stroke as a strategy for centres lacking of specialised interventional neuroradiologists.
Thrombolysis within six hours after stroke key to improve functional outcome
Results from the IST-3 study, presented at the European Stroke Conference in Lisbon, found that for the type of patients recruited, despite the early hazards, thrombolysis within six hours improved functional outcome in acute ischaemic stroke patients.
FDA approves pivotal study of Smartpatch Peripheral Nerve Stimulation System for post-stroke shoulder pain
The Smartpatch PNS System offers a medical device pain relief therapy that has the potential to be an alternative to pain medications, and their accompanying side-effects.
Important questions raised by the AMBULATE trial: a trial of treadmill and overground walking...
By Richard Lindley
We then decided to explore the value of treadmill training and overground walking as an intervention to improve walking in the more...
UK’s NICE issues draft guidance on the use of altelplase to reduce the long...
NICE has recommended alteplase within the NHS as long as treatment is started as early as possible within 4.5 hours after onset of stroke symptoms, and after intracranial haemorrhage has been excluded by appropriate imaging techniques.
Organisational aspects of providing an interventional radiology stroke service
By Arnd Doerfler and Stefan Schwab
The management of acute ischaemic stroke is rapidly developing. Clinical data suggest that interventional stroke treatment may provide superior clinical outcomes...
New mobile software enables physicians to consult on stroke cases anytime, from anywhere
First-of-its-kind mobile phone-based software technology may allow physicians to manage and consult on stroke cases in real time from anywhere in the world, a study presented at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting in San Diego, USA, showed.
Do pre-specified ASPECTS scores predict good outcome for acute ischaemic stroke patients by endovascular...
Interim results from the START trial, presented at Society of NeuroInterventional Surgery (SNIS, San Diego, USA) 9th Annual Meeting, show advancement in predicting which patients suffering from ischaemic stroke will benefit from endovascular therapy.
First patient enrolled in stem cell therapy study for stroke
A new US study looking at the safety and effectiveness of new medication developed from adult stem cells for the treatment of ischaemic stroke has opened at University Hospitals (UH) Case Medical Center, Cleveland, USA.
FDA approves BrainsGate stroke-treatment study
BrainsGate's stroke-treatment is designed to treat ischaemic strokes with 24 hours of an event. Current pharmaceutical treatments, which include tPA proteins, are permitted only within 3-4.5 hours of a stroke.
Advances may make time window less important in stroke treatment
A multicentre study evaluated the use of computed tomography (CT) perfusion imaging, regardless of time from symptom onset, in selecting patients for endovascular treatment with devices or clot-busting drugs used directly at the problem site in the brain.
Penumbra launches the Max System Reperfusion Catheters for acute ischaemic stroke patients
The Max system offers a fast, simplified cerebral thrombectomy procedure with single-operator, over-the-wire delivery, without the need for a large proximal balloon guide.
Strokes among young people often overlooked, international study finds
Strokes are not just a medical condition of the advanced age - younger people can also be affected. But in this group, many strokes remain "silent" or symptoms are being misinterpreted. These findings from a large-scale European study were presented at the 22nd Meeting of the European Neurological Society.
Taking the stroke unit to the patient reduces time from alarm to therapy decision
A randomised controlled trial published in The Lancet Neurology in May has shown that for patients with suspected stroke, treatment in a mobile stroke unit substantially reduced median time from call for help to therapy decision.
The current role of temporary endovascular bypass in acute stroke
By Maxim Mokin, Elad I Levy and Tareq Kass-Hout
Over the last decade, we have witnessed rapid advancement of endovascular techniques for acute ischaemic stroke treatment....
1 Mission 1 Million initiative works to improve stroke prevention in atrial fibrillation
1 Mission 1 Million - Getting to the Heart of Stroke announced plans to launch a new phase of the initiative dedicated to raise awareness of atrial fibrillation and its link to stroke.
SPS3 results do not support use of combination clopidogrel plus aspirin to prevent secondary...
Interim results from the SPS3 (Secondary prevention of small subcortical strokes) study, presented by Oscar Benavente, Vancouver, Canada, revealed that combination therapy using clopidogrel plus aspirin is not effective in preventing secondary strokes over the long term, in patients with small subcortical strokes.
Solitaire FR device approved for interventional management of stroke trial (IMS III)
The IMS III trial will compare a combined intravenous and intra-arterial treatment approach to restoring blood flow to the brain to the current standard FDA-approved treatment approach of giving IV rTPA alone.
A case for re-thinking the acute ischaemic stroke treatment algorithm
By Firas Al-Ali
The PROACT II trial had 42% good clinical outcome (mRS 0–2) following pharmacological intervention only and established two key criteria for good outcome:...
Clot-busting drugs appear safe for treating “wake-up” stroke patients
A study presented at the American Stroke Association's International Stroke Conference 2012 shows that clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms.
TREVO results presented at the International Stroke Conference
Results from the prospective, multicentre clinical study show that 55% of patients who suffered a severe acute ischaemic stroke were restored to a good functional outcome.
Solitaire FR approved for interventional management of stroke trial
The Solitaire FR revascularisation device (Covidien) has been approved for investigational use in the thrombectomy arm of the IMS III (Interventional management of stroke) trial.
Haemoglobin and blood pressure levels, male gender linked to “silent” strokes in children with...
Researchers from USA have found that lower concentrations of haemoglobin, higher baseline systolic blood pressure, and male gender are associated with a significantly increased risk of silent stroke in children with sickle cell anaemia.
First patient from a next dose cohort successfully treated in stem cell therapy clinical...
ReNeuron reported that the first patient of three to be treated with a higher dose cohort of ReN001 has been successfully discharged from hospital with no acute safety issues arising.
“Retrospective data shows safety and efficacy of Solitaire FR as a first choice revascularisation...
Data presented by Jan Gralla, Bern, Switzerland, at CIRSE 2011 in Munich, Germany, showed that Solitaire FR from ev3/Covidien had a good recanalisation rate and good patient outcome at 90 days, as measured by the modified Rankin Scale.
No strict time window or age limit to treat acute ischaemic stroke
Iris Q Grunwald, Oxford, UK, told delegates at the CIRSE annual meeting that mechanical recanalisation devices allow an extension of the conventional therapeutic time window and can be used without adjuvant thrombolytic therapy thus potentially reducing the intracranial bleeding risk in the treatment of acute ischaemic stroke.
Bioness receives FDA clearance and CE mark for the Ness H200 wireless system for...
The NESS H200 wireless is an advanced hand rehabilitation system designed to use mild functional electrical stimulation to improve hand function and promote motor recovery in patients who have lost function of their upper extremity following injury to the central nervous system.
Concentric Medical completes enrolment for mechanical thrombectomy in acute ischaemic stroke study
"The TREVO study represents an important step forward in the evidence supporting the treatment of patients with moderate and severe strokes with mechanical thrombectomy devices, such as the Trevo system (Concentric Medical/Stryker)," according to Nils Wahlgren, co-principal investigator of the study.
Non-invasive brain stimulation may improve swallowing after stroke
Stroke patients who received transcranial direct current stimulation coupled with swallowing exercises showed greater improvement in swallowing ability than patients who did not receive this stimulation, according to a pilot study reported in Stroke: Journal of the American Heart Association.
Clinical investigators address confusion over study of patent foramen ovale in stroke patients
Results in CLOSURE I study reinforce need for definitive study of patent foramen ovale in stroke patients.
Magnetic resonance imaging can help decide therapy in patients with unclear-onset stroke
Patients with unclear-onset strokes are usually excluded from clot-busting therapy because of lack of clarity on the beginning of their stroke symptoms; however research shows how magnetic resonance imaging can help to treat these patients safely.
Young, uninsured or Medicare Part D survivors often cannot afford medicines increasing risk for...
Despite the US government prescription coverage, data suggest that medicine is still unaffordable for some disadvantaged stroke survivors. The results were presented by Deborah A. Levine at the American Stroke Association's International Stroke Conference 2011.
“Robot therapy adds a new wrinkle to stroke rehabilitation strategies”
Kayoko Takahashi, Japan, explained how therapy in which robots manipulate paralysed arms, combined with standard rehabilitation, can improve arm and shoulder mobility in patients after stroke.
Advanced macular degeneration may be associated with an increased risk of bleeding stroke in...
The results of the Rotterdam study were presented by researchers from The Netherlands at the American Stroke Association's International Stroke Conference 2011.
Large stroke genetics research project gets funding
US$3.6 million grant from National Institutes of Health to fund research at 17 sites in USA and Europe to uncover genetic influences for prevention and treatment of stroke.
New guideline: MRI better than CT scans at diagnosing stroke
One study shows stroke accurately detected 83% of the time by MRI, versus 26% by CT.
New data suggest faster and less costly thrombectomy procedures with Zoom aspiration catheters
Imperative Care recently announced the publication of clinical data in the journal Interventional Neuroradiology (INR) detailing the use of its Zoom aspiration catheters in...
NeuroNews’ top 10 most popular stories of August 2023
Several presentations and news stories from this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) ended up among...
Mahesh Jayaraman becomes 28th president of the Society of NeuroInterventional Surgery
Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the...
Trial underway involving neurointerventionist “retaliated against” for refusing concurrent on-call shifts
The opening statements and presentation of evidence are set for 10am PST today in a lawsuit involving claims that a medical doctor and his...
IRRAS announces commercial US partnership with Medtronic for IRRAflow system
IRRAS recently announced it has signed a sales agency agreement to promote its IRRAflow system in the USA with Medtronic.
During the initial pilot phase of this...
Process times and regional variation are main areas of concern for thrombectomy care in...
Technical and clinical outcomes associated with mechanical thrombectomy treatments in England are currently “acceptable”, but ‘drip-and-ship’ patients, process times and variation between units all...
Route 92’s Monopoint operating platform shows 82% first-pass effect in independent study
Route 92 Medical recently announced the publication of an investigator-initiated, multicentre SLIC (Super large-bore ingestion of clot) study of its proprietary Monopoint operating platform,...
First commercial Vivistim patient set to begin paired vagus nerve stimulation therapy
MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) system for improved upper-limb function post-stroke. The company said...
Direct mechanical thrombectomy alone deemed non-inferior to its combination with alteplase
Investigators of the DIRECT-MT trial, who evaluated Chinese patients with acute ischaemic stroke from large-vessel occlusion, concluded that endovascular thrombectomy alone was non-inferior in...
Ghana making giant strides: Neurointerventional practice in sub-Saharan Africa
Since founding the Ghana Society of Interventional Radiologists in November 2015, Benjamin Dabo Sarkodie has been working to establish the offering of minimally invasive,...
Medtronic partners with Viz.ai to accelerate adoption of new AI software
Medtronic and Viz.ai have partnered to accelerate the adoption of Viz.ai’s new technology, which helps synchronise stroke care and decrease time to treatment, potentially...
Going beyond DAWN and DEFUSE 3: New studies point to need for expanded selection...
A series of studies published in the Journal of NeuroInterventional Surgery is bringing attention to potential constraints in the practice-changing DAWN and DEFUSE 3 trials, when...
Rapid Medical receives CE mark approval for TIGERTRIEVER 13
Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE mark approval for the...
Enrolment of ENRICH trial reaches 100 patients
More than 100 patients are now enrolled in the ENRICH randomised controlled trial. The trial is designed to compare the outcomes between early surgical...
MicroVention announces US FDA approval for neuro stent device
MicroVention has announced today the FDA Premarket Approval (PMA) for the LVIS and LVIS Jr. stents for stent-assisted coil embolisation of intracranial aneurysms. The LVIS and LVIS Jr....
State-of-the-art imaging solution provides automated scoring to assess early signs of brain ischaemia
At the European Stroke Organisation Conference, iSchemaView publicly launched RAPID ASPECTS, a digital imaging solution that assists clinicians in assessing early signs of brain...
“Drip-and drive” may be superior to “drip-and-ship”
Transferring interventional neuroradiologists (INR) to primary stroke centres to perform mechanical thrombectomy (“drip-and drive”) is feasible and could result in a significant reduction in...
CT perfusion mismatch for identifying thrombectomy patients
Computerised tomography (CT) perfusion mismatch criteria substantially increases the proportion of patients deemed eligible for thrombectomy compared to clinical core mismatch criteria and, despite...
Significant reduction in hospital workflow times with direct transfer to angiosuite
A new study from Barcelona has shown that in a subgroup of patients, direct transfer and triage in the angiosuite seems feasible, safe, and achieves significant...
Physiological time is brain
The DAWN trial results, presented at the European Stroke Organisation Conference (ESOC) by Tudor Jovin and Raul Nogueira, dramatically change the landscape for treatment...
Wanted: More interventionalists
As the number of patients eligible for endovascular treatment of acute ischaemic stroke increases, centres across Europe must consider whether there are enough interventionalists...
To give or not to give IV t-PA: That is the question
By Joshua A Hirsch
The year 2015 was a remarkable one for long-term proponents of endovascular therapy for strokes resultant from emergent large vessel occlusion...
Knowledge, experience and training are the calling cards of the mechanical thrombectomy operator
Now that the safety and efficacy of mechanical thrombectomy for the treatment of acute ischaemic stroke has been proven in at least five randomised...
First patient treated in ARISE II
Neuravi has announced that the Tennessee Interventional and Imaging Associates at Erlanger Medical Center in Chattanooga, USA, have treated the first patient in an...
Location makes a significant difference in stoke treatment in the USA
A new map of emergency stroke care in the USA illustrates the patchwork system in place for delivering the most effective treatment. In the...
Toshio Hyogo
Toshio Hyogo, current president of the World Federation of Interventional Neuroradiology (WFITN) and 2004 president of the Japanese Society of NeuroEndovascular Therapy tells NeuroNews...
Endovascular therapy under general anaesthesia linked to improved functional outcomes versus sedation
The multicentre, randomised SEGA trial has found that acute ischaemic stroke patients who receive endovascular therapy (EVT) under general anaesthesia experience better functional outcomes...
Route 92 announces positive clinical findings with Tenzing 7 delivery catheter
Route 92 Medical has announced new results from a multicentre clinical study evaluating the efficacy, safety and efficiency of the Tenzing 7 delivery catheter as a...
Current intracranial aneurysm literature reflects “a failure of the peer-review process”
A systematic review and meta-analysis of 1,356 studies and more than 410,000 patients have found that “methodological flaws and incomplete reporting” occur frequently in...
SVIN 2023 to champion innovation and inclusivity in “notable departure” from past meetings
In a “notable departure” from prior iterations of the conference, this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November, Miami,...
Robocath completes CARE clinical trial evaluating robotic carotid stenting
Robocath has today announced the results of its CARE clinical trial focusing on robotic carotid stenting—the first phase of a research programme launched in...
“The tables have turned”—US FDA regulation is becoming the envy of Europe
Discussions at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) revealed the extent of the disparities between the...
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82....
Contego announces enrolment of first patient in PERFORMANCE III trial
Contego Medical has announced enrolment of the first patient in the prospective, multicentre PERFORMANCE III trial aimed at further evaluating the safety and effectiveness...
NeuroNews’ top 10 most popular stories of September 2023
Exclusive interviews with multiple pioneering figures in the US neurovascular field earmark NeuroNews’ latest top 10, as do results from two ongoing studies attempting...
Remote teleproctoring helps neurointerventionists overcome wartime restrictions in Ukraine
Remote teleproctoring has demonstrated promising results in providing hands-on mechanical thrombectomy training and overcoming wartime migration restrictions in Ukraine, according to initial experiences published...
New AVM intervention findings “refute” ARUBA complication rates and may elicit further research
New data from an analysis of patients who would have been eligible for the ARUBA trial—which previously indicated medical management is likely favourable over...
Vesalio announces presentation of positive CLEAR study results at ESMINT 2023
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
Observation, creativity and happy accidents: Transitioning from clinical life to industry work
When it comes to advising young physicians on how to navigate the more commercial, industry-entwined commitments that their career will most likely bring further...
Rapid gains Chinese NMPA regulatory approval for Tigertriever thrombectomy device
Rapid Medical has announced Chinese National Medical Product Administration (NMPA) approval for its adjustable Tigertriever revascularisation device, making it the first device to offer...
Mount Sinai neurointerventionist J Mocco joins Protembis board of directors
Protembis has announced the appointment of J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) as an independent member of its...
Missing outcome data is common and ‘does not occur at random’ in thrombectomy registries
The phenomenon of missing outcome data (MOD) within stroke registries of mechanical thrombectomy cases “is not a rare event and does not occur completely...
NeuroNews’ top 10 most popular stories of July 2023
NeuroNews’ 10 most popular stories from July reveal a huge amount of interest in the treatment of stroke patients with medium vessel occlusions (MeVOs)—with...
Report finds improved thrombectomy access at NHS hospitals using Brainomix’s AI technology
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford...
New study finds surgical approaches safe and effective in ARUBA-eligible unruptured AVM patients
Contrary to the results of a seminal study in the field, a recent analysis presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting...
Route 92 announces publication of first-in-human study featuring FreeClimb 70 reperfusion system
Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology....
Recruitment in iVascular’s SEMTIC study passes halfway point
iVascular has announced that the SEMTIC study, evaluating the safety and efficacy of its comprehensive stroke thrombectomy treatment, is one step closer to providing...
“No significant difference” between aspiration and stent-retriever thrombectomy in medium vessel occlusions
When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or...
First US and French patients enrolled in Philips’ WE-TRUST study
Royal Philips has today announced enrolment of the first patients in both the USA and France into the large-scale WE-TRUST study—a multicentre, prospective randomised...
Is thrombectomy set to become the standard of care for medium vessel occlusions?
With multiple large clinical trials currently underway to assess thrombectomy treatments in patients with medium vessel occlusion (MeVO) stroke, Johanna Ospel (Calgary, Canada) takes...
“Definitive trial” needed to confirm desmopressin’s potential in ICH patients receiving antiplatelets
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the...
LINNC 2023 examines neuroprotection, steerable microcatheters and other ‘next frontiers’
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC...
Microvention announces commercial availability of ERIC retrieval device in the USA
Microvention, a wholly owned subsidiary of Terumo, has announced that the ERIC retrieval device is now commercially available in the USA for ischaemic stroke treatment, having...
US and Chinese experts introduce new aneurysmal subarachnoid haemorrhage guidelines
Expert groups from the USA and China have separately introduced new guidelines relating to the management of aneurysmal subarachnoid haemorrhage (aSAH). The updated guidelines—spearheaded...
J Mocco
As president of the Society of NeuroInterventional Surgery (SNIS), endovascular neurosurgeon J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) has...
AptaTargets announces publication of APRIL trial data in JAMA Neurology
As per a press release from AptaTargets, JAMA Neurology has published positive results from APRIL—a Phase 1b/2a clinical trial evaluating the safety and efficacy...
Safety benefits mean TCAR may be preferable approach in radiation-induced carotid stenosis
A study presented recently at the Vascular Annual Meeting (VAM; 14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery...
More research needed but lithotripsy plus TCAR ‘an answer’ in certain carotid disease patients
Earlier this year, researchers debuted single-centre experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularisation (TCAR) into patients with...
Imperative announces data demonstrating benefits of Zoom RDL system in neurointerventional procedures
Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial...
First-time data releases “confirm” Roadsaver carotid stent safety and efficacy
Presenting first-time data from large multicentre European studies at this year's Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany), Arne Schwindt (St Franziskus...
Early Feasibility Study programme has potential to advance US neurovascular space
At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation...
Combined thrombectomy technique fails to demonstrate superiority over aspiration alone
New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy...
TESLA trial misses primary endpoint but exhibits “strong suggestion” favouring endovascular therapy
The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion”...
Latest trial results prompt call to “elevate” intracranial haemorrhage management
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...
Pipeline Flex embolisation device deemed safe and effective in complex intracranial aneurysms
A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial...
Artiria granted US FDA clearance for real-time, deflectable guidewire
Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug...
Interim data find “no evidence of benefit” for carotid revascularisation additional to optimised medical...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
WEB 17 device maintains efficacy, safety across ruptured and unruptured aneurysms
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...
Open and endovascular surgery recommended over ligation in ruptured extracranial carotid aneurysms
Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms....
World-renowned clot science drives outstanding EMBOTRAP stent retriever outcomes in MASTRO I
This advertorial is sponsored by CERENOVUS.
The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design...
Medical therapy improvements mean “the time has come” to reconduct prior endarterectomy trials
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward...
NICO announces initial positive results from ENRICH trial
NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting...
ENRICH trial data on minimally invasive ICH surgery to be presented at AANS 2023
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...
NeuroNews’ top 10 most popular stories of March 2023
In addition to the US approval of a unique neurovascular device, discussions around female physicians in the neurointerventional space; pushback against the European Union’s...
Vitor Mendes Pereira
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Study finds “dismally low” global access to thrombectomy and “enormous disparity” between countries
The Society of Vascular and Interventional Neurology (SVIN) has released its first global analysis of access to mechanical thrombectomy for the treatment of large...
US physicians publish “first reported use” of Indigo aspiration system for novel indication
Physicians in the USA have published details of—to their knowledge—the “first reported use” of the Indigo aspiration system (Penumbra) to treat cerebral venous sinus...
NovaSignal announces donation of NovaGuide 2 intelligent ultrasound system to Jacobs Institute
NovaSignal has today announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA in order to advance stroke...
Hotter weather during transportation associated with improved thrombectomy outcomes
A study intended to examine the impact of different weather conditions and modes of transport on mechanical thrombectomies in stroke patients has found a...
Uric acid-based neuroprotective agent demonstrates promise in large animal study
The opening day of the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) saw the presentation of findings from an animal-model study that...
Vesalio announces successful initial use of NeVa VS device in USA
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral...
Randomised trial fails to show benefit with bypass surgery in symptomatic ICA/MCA occlusions
The initial findings from a recent randomised controlled trial (RCT) do not support the addition of extracranial to intracranial (EC-IC) bypass surgery to the...
Brainomix technology integrated into new UK atrial fibrillation study
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
MindMaze launches Izar neurological rehabilitation device in USA and Europe
MindMaze has announced the US and EU launch of Izar, which it describes as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked...
Blood pressure lowering after EVT “should be customised” owing to safety signals and marginal...
The administration of medications to lower systolic blood pressure in acute ischaemic stroke patients who have undergone a successful mechanical thrombectomy procedure—also known as...
Real-world study demonstrates “highly clinically important” time saving with Viz platform
Viz.ai and TeleSpecialists have announced new data presented at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) from the VALIDATE study, which...
Equivalency to clinical practice “varies considerably” across recent carotid intervention trials
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as...
Clinical trial to test novel wearable treatment for chronic pain and opioid withdrawal
A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will...
Atrial fibrillation does not modify treatment effect of bridging thrombolysis, study finds
An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify...
First human cases performed with high-frequency imaging offering “unprecedented potential” in neurovascular pathologies
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company...
So, you want to be a principal investigator?
A career in clinical research is perhaps a less formulaic and well-trodden path than the one into medicine itself, typically requiring relatively young and...
DISTAL trial will elucidate non-dominant M2, M3 and PCA occlusions but sparks debate over...
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 Decemb